Subscribe
Logo small
Search

AOTMiT: The Transparency Council will evaluate drugs, incl. for chronic lymphocytic leukemia and kidney cancer

MedExpress Team

Medexpress

Published Feb. 1, 2022 10:16

AOTMiT: The Transparency Council will evaluate drugs, incl. for chronic lymphocytic leukemia and kidney cancer - Header image
Źródło: AOTMiT

The agenda of the Republic of Poland on February 7 includes:

Preparation of a position on drug evaluation:

Imbruvica (ibrutinibum) under the drug scheme: B.92. "Treatmen...

Content locked

To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].

If you already have an account, please log in

Szukaj nowych pracowników

Dodaj ogłoszenie już za 4 zł dziennie*.

* 4 zł netto dziennie. Minimalny okres ekspozycji ogłoszenia to 30 dni.

Read also